Patents by Inventor Jeffery Alan Stafford

Jeffery Alan Stafford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemical compounds
    Patent number: 8114885
    Abstract: Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
    Type: Grant
    Filed: July 30, 2007
    Date of Patent: February 14, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Amogh Boloor, Mui Cheung, Philip Anthony Harris, Kevin Hinkle, Jeffery Alan Stafford, James Marvin Veal
  • Pyrimidineamines as angiogenesis modulators
    Patent number: 7858626
    Abstract: Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
    Type: Grant
    Filed: July 30, 2007
    Date of Patent: December 28, 2010
    Assignee: GlaxoSmithKline LLC
    Inventors: Amogh Boloor, Mui Cheung, Ronda Gayle Davis-Ward, Philip Anthony Harris, Kevin Hinkle, Christopher P. Lauderman, Robert Anthony Mook, Jr., Jeffery Alan Stafford, James Marvin Veal
  • CHEMICAL COMPOUNDS
    Publication number: 20100105712
    Abstract: Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
    Type: Application
    Filed: October 30, 2009
    Publication date: April 29, 2010
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Amogh Boloor, Mui Cheung, Philip Anthony Harris, Kevin Hinkle, Jeffery Alan Stafford, James Marvin Veal
  • Pyrimidineamines as angiogenesis modulators
    Patent number: 7262203
    Abstract: Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
    Type: Grant
    Filed: May 15, 2006
    Date of Patent: August 28, 2007
    Assignee: SmithKline Beecham Corporation
    Inventors: Amogh Boloor, Mui Cheung, Ronda Davis, Philip Anthony Harris, Kevin Hinkle, Robert Anthony Mook, Jr., Jeffery Alan Stafford, James Marvin Veal
  • Pyrimidineamines as angiogenesis modulators
    Patent number: 7105530
    Abstract: Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also Includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: September 12, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Amogh Boloor, Mui Cheung, Ronda Davis, Philip Anthony Harris, Kevin Hinkle, Robert Anthony Mook, Jr., Jeffery Alan Stafford, James Marvin Veal